Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 – APLT
GlobeNewswire· 2025-02-10 18:42
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.co ...
ISO 20022 Migration and SWIFT MX Messages Training – Prepare for the 2025 Deadline (Online Training - March 21, 2025)
GlobeNewswire· 2025-02-10 18:42
Dublin, Feb. 10, 2025 (GLOBE NEWSWIRE) -- The "ISO 20022 and SWIFT MX Messages (ONLINE EVENT: March 21, 2025)" training course has been added to ResearchAndMarkets.com's offering. For 40 years MT standard has enabled financial institutions to communicate effectively by providing industry automation and reducing the cost and risk of cross-border business which enabled the development of the correspondent banking system on which world trade depends. But the system is now being replaced by a new, more efficie ...
AMD: Don't Be Fooled By The Hype (Rating Downgrade)
Seeking Alpha· 2025-02-10 18:41
Advanced Micro Devices, Inc. (NASDAQ: AMD ) stock fell sharply after reporting Q4 earnings . On the surface, everything seemed to be going well for the company, with strong revenue growth, Data Center top line growing 70% and other positive figures.Equity Research Analyst with a broad career in the financial market, covered both Brazilian and global stocks. As a value investor, my analysis is primarily fundamental, focusing on identifying undervalued stocks with growth potential. Feel free to reach out for ...
Should Cisco Systems Stock be in Your Portfolio Pre-Q2 Earnings?
ZACKS· 2025-02-10 18:41
Cisco Systems (CSCO) is set to release its second-quarter fiscal 2025 results on Feb. 12.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.The company anticipates second-quarter fiscal 2025 revenues between $13.75 billion and $13.95 billion. Non-GAAP earnings are expected between 89 and 91 cents per share. The Zacks Consensus Estimate for revenues is pegged at $13.86 billion, indicating growth of 8.36% from the year-ago quarter’s reported figure. The consensus mark for earnings has been ...
Strength Seen in SolarWinds (SWI): Can Its 21.8% Jump Turn into More Strength?
ZACKS· 2025-02-10 18:41
SolarWinds (SWI) shares ended the last trading session 21.8% higher at $18.31. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 6.9% gain over the past four weeks.SolarWinds is benefiting from its Subscription First strategy, which has driven strong subscription and ARR growth, increased adoption of its Observability solutions, high customer retention, and a broad, diversified customer base, all contributing to sust ...
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Integral Ad Science Holding Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IAS
GlobeNewswire News Room· 2025-02-10 18:40
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Integral Ad Science Holding Corp. (NASDAQ: IAS) between March 2, 2023 and February 27, 2024, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 31, 2025. SO WHAT: If you purchased IAS common stock during the C ...
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Integral Ad Science Holding Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IAS
GlobeNewswire· 2025-02-10 18:40
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Integral Ad Science Holding Corp. (NASDAQ: IAS) between March 2, 2023 and February 27, 2024, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 31, 2025. SO WHAT: If you purchased IAS common stock during the C ...
Shareholders that lost money on Nextracker Inc.(NXT) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
GlobeNewswire News Room· 2025-02-10 18:39
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nextracker Inc. ("Nextracker" or the "Company") (NASDAQ: NXT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nextracker investors who were adversely affected by alleged securities fraud between February 1, 2024 and August 1, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/nextracker-inc-lawsuit- ...
Shareholders that lost money on Nextracker Inc.(NXT) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
GlobeNewswire· 2025-02-10 18:39
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nextracker Inc. ("Nextracker" or the "Company") (NASDAQ: NXT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nextracker investors who were adversely affected by alleged securities fraud between February 1, 2024 and August 1, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/nextracker-inc-lawsuit- ...
Testosterone Replacement Therapy Market Forecast Report 2025-2033, with Key Player Profiles for AbbVie, Clarus Therapeutics, Ferring Pharmaceuticals, Lupin, Pfizer, Teva Pharmaceuticals and More
GlobeNewswire· 2025-02-10 18:39
Global Testosterone Replacement Therapy Market Projected to Reach USD 2.73 Billion by 2033Dublin, Feb. 10, 2025 (GLOBE NEWSWIRE) -- The "Testosterone Replacement Therapy Market Report by Product Type, Active Ingredients, End User, and Region 2025-2033" report has been added to ResearchAndMarkets.com's offering.The global testosterone replacement therapy (TRT) market is experiencing significant growth, with a projected increase from USD 2.03 Billion in 2024 to USD 2.73 Billion by 2033 at a CAGR of 3.2% from ...